These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 37024509)

  • 21. Neuroprotection and neurogeneration in MS and its animal model EAE effected by glatiramer acetate.
    Arnon R; Aharoni R
    J Neural Transm (Vienna); 2009 Nov; 116(11):1443-9. PubMed ID: 19669693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
    Janssen A; Fiebiger S; Bros H; Hertwig L; Romero-Suarez S; Hamann I; Chanvillard C; Bellmann-Strobl J; Paul F; Millward JM; Infante-Duarte C
    PLoS One; 2015; 10(6):e0130251. PubMed ID: 26114502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glatiramer acetate treatment increases stability of spinal synapses and down regulates MHC I during the course of EAE.
    Scorisa JM; Freria CM; Victorio SC; Barbizan R; Zanon RG; Oliveira AL
    Int J Biol Sci; 2011; 7(8):1188-202. PubMed ID: 22043176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.
    Lalive PH; Neuhaus O; Benkhoucha M; Burger D; Hohlfeld R; Zamvil SS; Weber MS
    CNS Drugs; 2011 May; 25(5):401-14. PubMed ID: 21476611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.
    Mao P; Manczak M; Shirendeb UP; Reddy PH
    Biochim Biophys Acta; 2013 Dec; 1832(12):2322-31. PubMed ID: 24055980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-Caspr-conjugated gold nanoparticles emergence as a novel approach in the treatment of EAE animal model.
    Taghizadeh S; Motallebnezhad M; Aghaie T; Azimi M; Aghamajidi A; Salari AA; Bozorgmehr M; Assarezadegan MA; Jazayeri MH
    Metab Brain Dis; 2022 Oct; 37(7):2603-2613. PubMed ID: 35922733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
    Forte M; Gold BG; Marracci G; Chaudhary P; Basso E; Johnsen D; Yu X; Fowlkes J; Rahder M; Stem K; Bernardi P; Bourdette D
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7558-63. PubMed ID: 17463082
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
    Aharoni R; Sasson E; Blumenfeld-Katzir T; Eilam R; Sela M; Assaf Y; Arnon R
    Exp Neurol; 2013 Feb; 240():130-44. PubMed ID: 23153580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rab32 connects ER stress to mitochondrial defects in multiple sclerosis.
    Haile Y; Deng X; Ortiz-Sandoval C; Tahbaz N; Janowicz A; Lu JQ; Kerr BJ; Gutowski NJ; Holley JE; Eggleton P; Giuliani F; Simmen T
    J Neuroinflammation; 2017 Jan; 14(1):19. PubMed ID: 28115010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Mitochondrial Dysfunction in Experimental Autoimmune Encephalomyelitis (EAE) Models of Multiple Sclerosis.
    Ng X; Sadeghian M; Heales S; Hargreaves IP
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The mechanism of action of glatiramer acetate in multiple sclerosis and beyond.
    Aharoni R
    Autoimmun Rev; 2013 Mar; 12(5):543-53. PubMed ID: 23051633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation.
    Kasindi A; Fuchs DT; Koronyo Y; Rentsendorj A; Black KL; Koronyo-Hamaoui M
    Cells; 2022 May; 11(9):. PubMed ID: 35563884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeted Stage-Specific Inflammatory microRNA Profiling in Urine During Disease Progression in Experimental Autoimmune Encephalomyelitis: Markers of Disease Progression and Drug Response.
    Singh J; Deshpande M; Suhail H; Rattan R; Giri S
    J Neuroimmune Pharmacol; 2016 Mar; 11(1):84-97. PubMed ID: 26277791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Astrocyte disruption of neurovascular communication is linked to cortical damage in an animal model of multiple sclerosis.
    Eilam R; Segal M; Malach R; Sela M; Arnon R; Aharoni R
    Glia; 2018 May; 66(5):1098-1117. PubMed ID: 29424049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The immunoregulatory and neuroprotective effects of human adipose derived stem cells overexpressing IL-11 and IL-13 in the experimental autoimmune encephalomyelitis mice.
    Azimzadeh M; Mahmoodi M; Kazemi M; Hakemi MG; Jafarinia M; Eslami A; Salehi H; Amirpour N
    Int Immunopharmacol; 2020 Oct; 87():106808. PubMed ID: 32693359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glatiramer acetate-specific antibody titres in patients with relapsing / remitting multiple sclerosis and in experimental autoimmune encephalomyelitis.
    Bomprezzi R; Schaefer R; Reese V; Misra A; Vollmer TL; Kala M
    Scand J Immunol; 2011 Sep; 74(3):219-226. PubMed ID: 21615449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Featured Article: Modulation of the OGF-OGFr pathway alters cytokine profiles in experimental autoimmune encephalomyelitis and multiple sclerosis.
    Ludwig MD; Zagon IS; McLaughlin PJ
    Exp Biol Med (Maywood); 2018 Feb; 243(4):361-369. PubMed ID: 29307283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Placental Extract and Exosomes Derived from Pregnant Mice Attenuate the Development of Experimental Autoimmune Encephalomyelitis.
    Motallebnezhad M; Taghizadeh S; Aghaie T; Azimi M; Salari AA; Bozorgmehr M; Safari E; Falak R; Jazayeri MH
    Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):657-669. PubMed ID: 36640057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.